FENC - Financial Reports List - Fennec Pharmaceuticals Inc. - IntrinsicAlpha

Fennec Pharmaceuticals Inc. FENC

Healthcare - Biotechnology - NASDAQ - US

$ 5.44

2.56 %

$ 150 M

Market Cap

-260.5

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-18.59%	39.63%	48.62%
Annual Report	FY	10-K	2024-12-31	123.69%	97.28%	120.11%
Quarterly Report	Q3	8-K	2024-09-30	7.05%	-207.18%	-411.50%
Quarterly Report	Q2	8-K	2024-06-30	118.41%	-2.00%	-7.99%
Quarterly Report	Q1	8-K	2024-03-31	1413.24%	312.11%	360.78%
Quarterly Report	Q4	8-K	2023-12-31	534.20%	65.58%	70.37%
Annual Report	FY	10-K	2023-12-31	1284.50%	35.40%	43.46%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	77.12%	87.12%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-7.63%	6.85%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-59.77%	-48.62%

1